Pharma stocks showed mixed movement in early trade today with selective buying in mid and small-cap names while several large-cap and mid-cap names traded with mild to moderate declines.
Broader market remained slightly positive with Nifty 50 trading around 25,147 level (up approximately 0.40%), while pharma counters witnessed more stock-specific action rather than any uniform sectoral trend.
Top Gainers in Early Trade (Selected Strong Performers)
- Beta Drugs — +3.87% (NSE)
- EMCure Pharmaceuticals — +2.23% (BSE) / +1.22% (NSE)
- Granules India — +2.11% (BSE) / +1.75% (NSE)
- J.B. Chemicals — +1.90% (BSE) / +1.52% (NSE)
- Wockhardt — +1.94% (BSE) / +1.09% (NSE)
- Innova Captab — +1.96% (BSE) / +3.38% (NSE)
- Thyrocare Technologies — +2.51% (BSE)
- Torrent Pharma — +1.09% (BSE) / +0.96% (NSE)
- Laurus Labs — +1.46% (BSE) / +1.39% (NSE)
Many of these names belong to the mid and small-cap space where momentum was comparatively better in the morning session.
Stocks Trading with Noticeable Decline
- Syngene International — -6.51% to -7.18% (sharpest fall in the list)
- Onesource Specialty Pharma — -6.56% to -6.79%
- Jubilant Industries — -4.08% to -4.46%
- Concord Biotech — around -2%
- Natco Pharma — -1.98% to -2.31%
- Anthem Biosciences — -1.81% to -2.50%
- Panacea Biotech — -2.51% to -2.88%
Several large-cap names like Cipla (-1.2% approx), Alembic Pharma (-1% approx), AstraZeneca Pharma (-1.2% approx), Abbott India (-0.8% to -1.1%) and Mankind Pharma (around -1%) were also trading mildly in the red.
Note: All percentage changes are as of 9:47 AM IST and can change significantly during the trading session.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.